Seo-Kyung Chung

Seo-Kyung Chung

Auto-generated profile, based on publicly available information

Seo-Kyung Chung

Institute of Life Sciences, Swansea University Medical School, Swansea University, UK

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
YFYen-Chen Anne Feng
Yen-Chen Anne Feng
DHDaniel P. Howrigan
Daniel P. Howrigan
LALiam E. Abbott
Liam E. Abbott
KTKatherine Tashman
Katherine Tashman
FCFelecia Cerrato
Felecia Cerrato
BNBenjamin M. Neale
Benjamin M. Neale

1 August 2016 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
CMCandace T. Myers
Candace T. Myers
JMJacinta M. McMahon
Jacinta M. McMahon
ASAmy L. Schneider
Amy L. Schneider
SPSlavé Petrovski
Slavé Petrovski
AAAndrew S. Allen
Andrew S. Allen
HMHeather C. Mefford
Heather C. Mefford

4 June 2006 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MRMark I Rees
Mark I Rees
KHKirsten Harvey
Kirsten Harvey
BPBrian R Pearce
Brian R Pearce
SCSeo-Kyung Chung
Seo-Kyung Chung
IDIan C Duguid
Ian C Duguid
Robert HarveyRobert Harvey
Robert Harvey

1 February 2017 in The Lancet Neurology
Verified
Journal Article
Open access
AAAndrew S Allen
Andrew S Allen
SBSusannah T Bellows
Susannah T Bellows
SBSamuel F Berkovic
Samuel F Berkovic
JBJoshua Bridgers
Joshua Bridgers
RBRosemary Burgess
Rosemary Burgess
MWMelodie R Winawer
Melodie R Winawer
Despite progress in understanding the genetics of rare epilepsies, the more common epilepsies have proven less amenable to traditional gene-discovery analyses. We aimed to assess the contribution of ultra-rare genetic variation to common epilepsies. We did a case-control sequencing study with exome sequence data from unrelated individuals clinically evaluated for one of the two most common epilepsy syndromes: familial genetic generalised epilepsy, or familial or sporadic non-acquired focal epilepsy. Individuals of any age were recruited between Nov 26, 2007, and Aug 2, 2013, through the multicentre Epilepsy Phenome/Genome Project and Epi4K collaborations, and samples were sequenced at the Institute for Genomic Medicine (New York, USA) between Feb 6, 2013, and Aug 18, 2015. To identify epilepsy risk signals, we tested all protein-coding genes for an excess of ultra-rare genetic variation among the cases, compared with control samples with no known epilepsy or epilepsy comorbidity sequenced through unrelated studies. We separately compared the sequence data from 640 individuals with familial genetic generalised epilepsy and 525 individuals with familial non-acquired focal epilepsy to the same group of 3877 controls, and found significantly higher rates of ultra-rare deleterious variation in genes established as causative for dominant epilepsy disorders (familial genetic generalised epilepsy: odd ratio [OR] 2·3, 95% CI 1·7-3·2, p=9·1 × 10-8; familial non-acquired focal epilepsy 3·6, 2·7-4·9, p=1·1 × 10-17). Comparison of an additional cohort of 662 individuals with sporadic non-acquired focal epilepsy to controls did not identify study-wide significant signals. For the individuals with familial non-acquired focal epilepsy, we found that five known epilepsy genes ranked as the top five genes enriched for ultra-rare deleterious variation. After accounting for the control carrier rate, we estimate that these five genes contribute to the risk of epilepsy in approximately 8% of individuals with familial non-acquired focal epilepsy. Our analyses showed that no individual gene was significantly associated with familial genetic generalised epilepsy; however, known epilepsy genes had lower p values relative to the rest of the protein-coding genes (p=5·8 × 10-8) that were lower than expected from a random sampling of genes. We identified excess ultra-rare variation in known epilepsy genes, which establishes a clear connection between the genetics of common and rare, severe epilepsies, and shows that the variants responsible for epilepsy risk are exceptionally rare in the general population. Our results suggest that the emerging paradigm of targeting of treatments to the genetic cause in rare devastating epilepsies might also extend to a proportion of common epilepsies. These findings might allow clinicians to broadly explain the cause of these syndromes to patients, and lay the foundation for possible precision treatments in the future. National Institute of Neurological Disorders and Stroke (NINDS), and Epilepsy Research UK.

29 January 2013 in Brain
Verified
Journal Article
Open access
PDF file
TCThomas Cushion
Thomas Cushion
WDWilliam B. Dobyns
William B. Dobyns
JMJonathan G. L. Mullins
Jonathan G. L. Mullins
NSNeil Stoodley
Neil Stoodley
SCSeo-Kyung Chung
Seo-Kyung Chung
DPDaniela T. Pilz
Daniela T. Pilz
Polymicrogyria and lissencephaly are causally heterogeneous disorders of cortical brain development, with distinct neuropathological and neuroimaging patterns. They can be associated with additional structural cerebral anomalies, and recurrent phenotypic patterns have led to identification of recognizable syndromes. The lissencephalies are usually single-gene disorders affecting neuronal migration during cerebral cortical development. Polymicrogyria has been associated with genetic and environmental causes and is considered a malformation secondary to abnormal post-migrational development. However, the aetiology in many individuals with these cortical malformations is still unknown. During the past few years, mutations in a number of neuron-specific α- and β-tubulin genes have been identified in both lissencephaly and polymicrogyria, usually associated with additional cerebral anomalies including callosal hypoplasia or agenesis, abnormal basal ganglia and cerebellar hypoplasia. The tubulin proteins form heterodimers that incorporate into microtubules, cytoskeletal structures essential for cell motility and function. In this study, we sequenced the TUBB2B and TUBA1A coding regions in 47 patients with a diagnosis of polymicrogyria and five with an atypical lissencephaly on neuroimaging. We identified four β-tubulin and two α-tubulin mutations in patients with a spectrum of cortical and extra-cortical anomalies. Dysmorphic basal ganglia with an abnormal internal capsule were the most consistent feature. One of the patients with a TUBB2B mutation had a lissencephalic phenotype, similar to that previously associated with a TUBA1A mutation. The remainder had a polymicrogyria-like cortical dysplasia, but the grey matter malformation was not typical of that seen in ‘classical’ polymicrogyria. We propose that the cortical malformations associated with these genes represent a recognizable tubulinopathy-associated spectrum that ranges from lissencephalic to polymicrogyric cortical dysplasias, suggesting shared pathogenic mechanisms in terms of microtubular function and interaction with microtubule-associated proteins.

1 April 2014 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
TCThomas Cushion
Thomas Cushion
APAlex R. Paciorkowski
Alex R. Paciorkowski
DPDaniela T. Pilz
Daniela T. Pilz
JMJonathan G.L. Mullins
Jonathan G.L. Mullins
LSLaurie E. Seltzer
Laurie E. Seltzer
WDWilliam B. Dobyns
William B. Dobyns